Cargando…
Peroxiredoxin II with dermal mesenchymal stem cells accelerates wound healing
Peroxiredoxin II (Prx II) is involved in proliferation, differentiation, and aging in various cell types. However, Prx II-mediated stem cell regulation is poorly understood. Here, dermal mesenchymal stem cells (DMSCs), cell-growth factor-rich conditioned medium from DMSCs (DMSC-CM), and DMSC-derived...
Autores principales: | Jin, Mei-Hua, Yu, Nan-Nan, Jin, Ying-Hua, Mao, Ying-Ying, Feng, Lin, Liu, Yue, Wang, Ai-Guo, Sun, Hu-Nan, Kwon, Taeho, Han, Ying-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202850/ https://www.ncbi.nlm.nih.gov/pubmed/34030134 http://dx.doi.org/10.18632/aging.202990 |
Ejemplares similares
-
Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathway
por: Han, Ying-Hao, et al.
Publicado: (2023) -
Peroxiredoxin II Maintains the Mitochondrial Membrane Potential against Alcohol-Induced Apoptosis in HT22 Cells
por: Jin, Mei-Hua, et al.
Publicado: (2019) -
Depletion of peroxiredoxin II promotes keratinocyte apoptosis and alleviates psoriatic skin lesions via the PI3K/AKT/GSK3β signaling axis
por: Han, Ying-Hao, et al.
Publicado: (2023) -
Peroxiredoxin I deficiency increases pancreatic β-cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathway
por: Jin, Mei-Hua, et al.
Publicado: (2020) -
Knockdown of Peroxiredoxin V increased the cytotoxicity of non-thermal plasma-treated culture medium to A549 cells
por: Sun, Hu-Nan, et al.
Publicado: (2022)